The EMPEROR-Preserved trial compared the efficacy and safety of empagliflozin with placebo in adults with heart failure and preserved ejection fraction, with and without diabetes.
High rate of fistula use, low rates of secondary procedures and complications seen at 5 years
Avoiding unnecessary medications in CKD might reduce the risks for adverse outcomes, investigators suggested.
For each 1-degree Celsius increase in daily mean temperature, estimated risk for hospitalization for renal diseases increased by 0.9%
Associations identified for glycochenodeoxycholate, O-methylcatechol sulfate, and 3-methyl catechol sulfate
In cohort of individuals with diabetes, no association seen for chronic kidney disease stage 3 to 5 with atopic eczema, psoriasis
Dialysis personnel are often the first providers to identify patients at risk for complications and adverse events, according to investigators.
Prescribers need to weigh the clinical benefits and potential cardiac risks of respiratory fluoroquinolones and amoxicillin-based antibiotics on an individual basis.
More than a third of patients required interventions to foster AVF maturation.
Investigators found a 27% decreased risk of kidney adverse events in a study of patients with normal kidney function or mild-to-moderate chronic kidney disease.